INS and type 1 diabetes mellitus: In conclusion, we showed in a preclinical model of T1D that empagliflozin and GABAld improved glucose homeostasis, islet density and insulin area/islet area ratios, and lipid metabolism through a reduction of ER and oxidative stress within the pancreas.